Zhejiang Hisun Pharmaceutical Co., Ltd. (SHSE:600267) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at a price not exceeding CNY 13 per share.

The repurchases will be funded using the company's own funds. The shares repurchased will be used for implementing the employee stock ownership plan. The repurchase program will be valid for 12 months.